Great write up. I’ve been holding nvta since March and am up about 10%. I wanted to add that United Health Insurance - one of the big boys - recently named nvta as a preferred lab tester in its network (it was one out of a handful named - https://www.cmlviz.com/2019/04/22/NVTA/invitae-nvta-gets-a-h…).
My brother is also a heart doctor, and he told me these genetic tests are what the medical industry relies on when there is insufficient family medical history. Think of all the people that don’t know their family medical history or are too old to have had accurate diagnoses for their parents/grandparents.
I also think the world is switching to preventive measures instead of treatment of existing diseases. It reminds me of the tobacco industry. Everybody realized that the cost of treatment for tobacco related cancers was costing the states a fortune so they dumped a ton of money into stopping smoking before it begins (after tobacco got their asses sued off) … and the rest is history. I think insurance companies are starting to realize it’s CHEAPER for them to nip diseases in the bud instead of treat them. Genetic tests are the way to do this.
Finally, NVTA helps pregnant women and potential cancer patients (usually elder). There should always be a stream of new customers, or civilization has bigger problems.
As a new holder, I’m excited to hear about tomorrow’s earnings. The main point of focus for me will be how many more tests they’ve performed than this time last year.
Best,
BTL
Long NVTA